Moderna (MRNA) Inks Genetic Medicines Deal With Generation Bio

Published on 25 Mar 2023 on Zacks via Yahoo Finance

Moderna (MRNA) Inks Genetic Medicines Deal With Generation Bio

Moderna MRNA announced a strategic collaboration with Generation Bio GBIO to develop non-viral gene therapies. For this, it will leverage the latter’s core technologies, closed-end DNA (ceDNA) and cell-targeted lipid nanoparticle delivery system (ctLNP) technologies. In the past year, shares of Moderna have plunged 9.9% compared with the industry's 14.8% decline.

Zacks Investment Research

Image Source: Zacks Investment Research

Read the rest of the article

NASDAQ.MRNA price evolution

NASDAQ.GBIO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...

Key Insights Significantly high institutional ownership implies Moderna's stock price is sensitiv...

Simply Wall St. via Yahoo Finance 9 May 2024

Moderna’s mRNA Dreams Meet Reality With First Post-Covid Shot

(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...

Bloomberg via Yahoo Finance 9 May 2024

Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript

Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript May 2, 2024 Moderna, Inc. beats earn...

Insider Monkey via Yahoo Finance 4 May 2024

Decoding Moderna Inc (MRNA): A Strategic SWOT Insight

Moderna Inc (NASDAQ:MRNA) faces a significant decrease in revenue and net income, reflecting a 91...

GuruFocus.com via Yahoo Finance 4 May 2024

Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...

Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Fo...

Benzinga via Yahoo Finance 2 May 2024

Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y

Moderna, Inc. MRNA reported earnings of $3.07 per share in the first quarter of 2024, beating the...

Zacks via Yahoo Finance 2 May 2024

Why Earnings Season Could Be Great for Moderna (MRNA)

Investors are always looking for stocks that are poised to beat at earnings season and Moderna, I...

Zacks via Yahoo Finance 1 May 2024

We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO...

Key Insights Moderna to hold its Annual General Meeting on 6th of MayCEO Stephane Bancel's total ...

Simply Wall St. via Yahoo Finance 30 Apr 2024

mRNA Is Promising A Breakthrough In Fighting Cancer

mRNA Is Promising A Breakthrough In Fighting Cancer When it comes to cancer, there’s innovation b...

Benzinga via Yahoo Finance 29 Apr 2024

Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect

Moderna MRNA will report first-quarter 2024 results on May 2, before the opening bell. In the las...

Zacks via Yahoo Finance 29 Apr 2024

News

Moderna (MRNA) Inks Genetic Medicines Deal With Generation Bio

NASDAQ.MRNA price evolution

NASDAQ.GBIO price evolution

Want to become a better investor?